Northwest Bioth Cmn (OP: NWBO )

1.355 USD +0.040 (+3.04%)

Streaming Delayed Price Updated: 1:08 PM EST, Jan 15, 2021 Add to My Watchlist

Price and Volume

Volume	2,163,104
Open	1.370
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	1.315
Today's Range	1.290 - 1.398
52wk Range	0.1400 - 2.510
Shares Outstanding	419,465,016
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Promising New Cancer Treatments Advancing Through The Pipeline In Over $200 Billion Dollar Drug Market

October 21, 2020

Promising New Cancer Treatments Advancing Through The Pipeline In Over $200 Billion Dollar Drug Market

October 21, 2020

Financialnewsmedia.com News Commentary

Performance

YTD	-16.36%	-16.36%
1 Month	+6.40%	+6.40%
3 Month	-5.90%	-5.90%
6 Month	+298.53%	+298.53%
1 Year	+545.24%	+545.24%

More News

Northwest Biotherapeutics Announces Data Lock of Phase III Trial

October 05, 2020

Northwest Biotherapeutics Acquires Flaskworks

September 01, 2020

NW Bio Accelerating Sawston Plant Phase I Buildout

August 27, 2020

Northwest Biotherapeutics Announces $5 Million Financing

August 21, 2020

NW Bio Announces Completion of Further Data Gathering For Phase III Trial

August 19, 2020

Northwest Biotherapeutics Announces $8 Million Financing

August 11, 2020

Northwest Biotherapeutics Announces Completion of Phase 3 Trial Sites' Databases

July 24, 2020

NW Bio Provides Update On Projected Timing For Data Lock For Phase 3 Trial of DCVax®-L for Glioblastoma Brain Cancer

June 02, 2020

NW Bio To Discuss Projected Schedule For Data Lock, Unblinding and Top Line Data From Its Phase 3 Clinical Trial At Annual Shareholder Meeting

April 18, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.